2-Chloroadenosine (2-CADO) treatment modulates the pro-inflammatory immune response to prevent acute lung inflammation in BALB/c mice suffering from Klebsiella pneumoniae B5055-induced pneumonia

Martin, 2000, High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock, Crit Care Med, 28, 3198, 10.1097/00003246-200009000-00014 Harada, 2000, Adenosine and selective A2A receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation, J Pharmacol Exp Ther, 294, 1034 Cavalcante, 2006, Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis, Infect Immun, 74, 2606, 10.1128/IAI.74.5.2606-2612.2006 Held, 1998, Granulocyte colony-stimulating factor worsens the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria, Blood, 91, 2525 Yadav, 2003, Induction and resolution of lobar pneumonia following intranasal instillation with Klebsiella pneumoniae in mice, Indian J Med Res, 118, 47 Reutershan, 2007, Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2A stimulation in lipopolysaccharide-induced lung injury, J Immunol, 179, 1254, 10.4049/jimmunol.179.2.1254 Takahashi, 2007, Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activated, Br J Pharmacol, 150, 816, 10.1038/sj.bjp.0707126 Haskó, 1996, Adenosine receptor agonists differentially regulate IL-10, TNF-α and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice, J Immunol, 157, 4634, 10.4049/jimmunol.157.10.4634 Delclaux, 2003, Inflammatory response to infectious pulmonary injury, Eur Respir J, 22, 10s, 10.1183/09031936.03.00420203 Mosmann, 1994, Properties and function of interleukin-10, Adv Immunol, 56, 1, 10.1016/S0065-2776(08)60449-6 Sakamaki, 2003, Attenuation by intravenous 2-chloroadenosine of acute lung injury induced by live Escherichia coli or latex particles added to endotoxin in the neutropenic state, J Lab Clin Med, 142, 128, 10.1016/S0022-2143(03)00105-7 Chen, 2008, Adenosine, through the A1 receptor, inhibits vesicular MHC class I cross-presentation by resting DC, Mol Immunol, 45, 2247, 10.1016/j.molimm.2007.11.016